Human OX40L-CAR-Tregs target activated antigen-presenting cells and control T cell alloreactivity. Sci Transl Med. 2024 Oct 16; 16(769):eadj9331. View Human OX40L-CAR-Tregs target activated antigen-presenting cells and control T cell alloreactivity. Abstract

COVID-19-Associated Croup in Children. Pediatrics. 2022 06 01; 149(6). View COVID-19-Associated Croup in Children. Abstract

TLR7 is expressed by support cells, but not sensory neurons, in ganglia. J Neuroinflammation. 2021 Sep 16; 18(1):209. View TLR7 is expressed by support cells, but not sensory neurons, in ganglia. Abstract

Chronic cerebral lipocalin 2 exposure elicits hippocampal neuronal dysfunction and cognitive impairment. Brain Behav Immun. 2021 10; 97:102-118. View Chronic cerebral lipocalin 2 exposure elicits hippocampal neuronal dysfunction and cognitive impairment. Abstract

Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia. Nat Commun. 2021 04 06; 12(1):2057. View Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia. Abstract

Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 1-July 25, 2020. MMWR Morb Mortal Wkly Rep. 2020 Aug 14; 69(32):1081-1088. View Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 1-July 25, 2020. Abstract

Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer. Elife. 2020 05 11; 9. View Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer. Abstract

Microglia in the hypothalamus respond to tumor-derived factors and are protective against cachexia during pancreatic cancer. Glia. 2020 07; 68(7):1479-1494. View Microglia in the hypothalamus respond to tumor-derived factors and are protective against cachexia during pancreatic cancer. Abstract

Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer. Nat Commun. 2019 Nov 15; 10(1):5257. View Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer. Abstract

The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer. Nat Commun. 2019 10 15; 10(1):4682. View The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer. Abstract

Persistent Toll-like receptor 7 stimulation induces behavioral and molecular innate immune tolerance. Brain Behav Immun. 2019 11; 82:338-353. View Persistent Toll-like receptor 7 stimulation induces behavioral and molecular innate immune tolerance. Abstract

MyD88 signalling is critical in the development of pancreatic cancer cachexia. J Cachexia Sarcopenia Muscle. 2019 04; 10(2):378-390. View MyD88 signalling is critical in the development of pancreatic cancer cachexia. Abstract

Increasing lean muscle mass in mice via nanoparticle-mediated hepatic delivery of follistatin mRNA. Theranostics. 2018; 8(19):5276-5288. View Increasing lean muscle mass in mice via nanoparticle-mediated hepatic delivery of follistatin mRNA. Abstract

TRIF is a key inflammatory mediator of acute sickness behavior and cancer cachexia. Brain Behav Immun. 2018 10; 73:364-374. View TRIF is a key inflammatory mediator of acute sickness behavior and cancer cachexia. Abstract

Establishment and characterization of a novel murine model of pancreatic cancer cachexia. J Cachexia Sarcopenia Muscle. 2017 Oct; 8(5):824-838. View Establishment and characterization of a novel murine model of pancreatic cancer cachexia. Abstract

A distinct brain pathway links viral RNA exposure to sickness behavior. Sci Rep. 2016 07 20; 6:29885. View A distinct brain pathway links viral RNA exposure to sickness behavior. Abstract

The central role of hypothalamic inflammation in the acute illness response and cachexia. Semin Cell Dev Biol. 2016 06; 54:42-52. View The central role of hypothalamic inflammation in the acute illness response and cachexia. Abstract

Sustained hyperoxia-induced NF-?B activation improves survival and preserves lung development in neonatal mice. Am J Physiol Lung Cell Mol Physiol. 2014 Jun 15; 306(12):L1078-89. View Sustained hyperoxia-induced NF-?B activation improves survival and preserves lung development in neonatal mice. Abstract

I?Bß-mediated NF-?B activation confers protection against hyperoxic lung injury. Am J Respir Cell Mol Biol. 2014 Feb; 50(2):429-38. View I?Bß-mediated NF-?B activation confers protection against hyperoxic lung injury. Abstract

The NF-?B inhibitory proteins I?Ba and I?Bß mediate disparate responses to inflammation in fetal pulmonary endothelial cells. J Immunol. 2013 Mar 15; 190(6):2913-23. View The NF-?B inhibitory proteins I?Ba and I?Bß mediate disparate responses to inflammation in fetal pulmonary endothelial cells. Abstract

Reprimo (RPRM) is a novel tumor suppressor in pituitary tumors and regulates survival, proliferation, and tumorigenicity. Endocrinology. 2012 Jul; 153(7):2963-73. View Reprimo (RPRM) is a novel tumor suppressor in pituitary tumors and regulates survival, proliferation, and tumorigenicity. Abstract

Nuclear factor-?B (NF-?B) inhibitory protein I?Bß determines apoptotic cell death following exposure to oxidative stress. J Biol Chem. 2012 Feb 24; 287(9):6230-9. View Nuclear factor-?B (NF-?B) inhibitory protein I?Bß determines apoptotic cell death following exposure to oxidative stress. Abstract

Identification of growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a novel tumor suppressor in pituitary gonadotrope tumors. Endocrinology. 2011 Oct; 152(10):3603-13. View Identification of growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a novel tumor suppressor in pituitary gonadotrope tumors. Abstract

Giant pituitary adenomas: pathologic-radiographic correlations and lack of role for p53 and MIB-1 labeling. Am J Surg Pathol. 2011 Aug; 35(8):1204-13. View Giant pituitary adenomas: pathologic-radiographic correlations and lack of role for p53 and MIB-1 labeling. Abstract